Dimitri Kullmann is a Professor of Neurology at the UCL Queen Square Institute of Neurology, in the Research Department for Clinical and Experimental Epilepsy. He studied medicine in Oxford and London, and completed a DPhil in Oxford. Following postdoctoral research in San Francisco, he established a laboratory at the Institute ot Neurology and completed his neurology training at the National Hospital for Neurology and Neurosurgery, Queen Square, where he continues to practise. His research interests include the fundamental mechanisms of synaptic transmission, neurological channelopathies and gene therapy for epilepsy. Together with colleagues at UCL he recently co-founded a spinout company that aims to bring gene therapy to the clinic. He was previously the Editor-in-Chief of the neurology journal Brain, and is a Fellow of the Royal Society and of the Academy of Medical Sciences. As Deputy Director for Enterprise, Translation and Advanced Therapies, he is working with Dr Eleonora Lugarà to facilitate the translation of discoveries made by researchers at the Institute of Neurology for patient benefit.
Close